[Corrections] Corrections

Gilhus N E. Eculizumab: a treatment option for myasthenia gravis? Lancet Neurol 2017; 16: 947 –48—The original title of this comment was “Eculizumab: a treatment option for mysthenia gravis?”. This title has been corrected to “Eculizumab: a treatment option for myasthenia gravis?”. This correction has been made to the online version as of Dec 15, 2017.
Source: Lancet Neurology - Category: Neurology Tags: Corrections Source Type: research